India supplies over 45 per cent of generic drugs and 15 per cent of biosimilars used in the US. Major Indian firms such as Dr Reddy’s, Sun Pharma, Aurobindo Pharma, Zydus Lifesciences, and Gland Pharma reportedly earn 30–50 per cent of their total revenue from the American market.